Stock DNA
Chemicals & Petrochemicals
USD 49,540 Million (Large Cap)
37.00
NA
98.86%
0.05
5.72%
1.91
Total Returns (Price + Dividend) 
Corteva, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Corteva, Inc. overvalued or undervalued?
As of 7 November 2025, the valuation grade for Corteva, Inc. has moved from expensive to fair. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 37, a Price to Book Value of 2.01, and an EV to EBITDA of 14.55. In comparison, a peer company shows a P/E of 33.44, indicating that Corteva is slightly more expensive than its peer, while its EV to EBITDA is comparable. Corteva's recent stock performance has outpaced the S&P 500 in the short term, with a 1-week return of 5.64% compared to the S&P 500's -1.63%. However, over a longer horizon, such as the 3-year and 5-year periods, Corteva's returns lag behind the S&P 500, suggesting some caution for long-term investors....
Read MoreIs Corteva, Inc. overvalued or undervalued?
As of 7 November 2025, Corteva, Inc. has moved from expensive to fair valuation. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 37, a Price to Book Value of 2.01, and an EV to EBITDA of 14.55. In comparison, a peer like Corteva, Inc. shows a higher P/E of 33.44, indicating that while it is perceived as very expensive, it still reflects a competitive landscape in the Chemicals & Petrochemicals industry. Recent stock performance reveals that Corteva has outperformed the S&P 500 over the past week with a return of 4.41% compared to the S&P 500's -1.63%, although it has lagged behind over longer periods, such as the 3-year and 10-year returns. Overall, the valuation metrics suggest that Corteva is fairly valued relative to its peers and market conditions....
Read More
Corteva Opens Weak with 3.04% Gap Down Amid Market Concerns
Corteva, Inc. opened with a notable loss, reflecting a broader trend in its stock performance. The company has a market capitalization of approximately USD 49,540 million and a P/E ratio of 37.00. It features a high dividend yield and a low debt-to-equity ratio, indicating financial stability.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 162 Schemes (42.99%)
Held by 413 Foreign Institutions (15.89%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 5.63% vs 1.11% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 30.87% vs 20.00% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -1.85% vs -1.31% in Dec 2023
YoY Growth in year ended Dec 2024 is -8.29% vs -22.62% in Dec 2023






